Abstract
The purpose of this study: Musculoskeletal tumors are very rare, and their distribution varies regionally. We aim to share the musculoskeletal system tumors and tumor-like lesions that orthopedic surgeons in the region commonly encounter in their daily practice.Methods. In this retrospective study, 339 patients diagnosed with tumor and tumor-like lesions in the musculoskeletal system who consulted a single orthopedic surgeon between 2022 and 2023 in a tertiary hospital in the Southeast of the country were included. Age, gender, size, type of lesions, tumor diagnoses, and anatomical sites were examined.Results. Bone localization (62.8%) is more common than soft tissue. Benign lesions are most commonly seen in both bone and soft tissue. Osteochondroma (21.7%) and chondrosarcoma (54%) are the most common benign and malignant bone tumors, while osteomyelitis (47.6%) is the most common tumor-like lesion. Hemangioma (27%) and peripheral nerve sheath tumor (62.5%) are the most common benign and malignant soft tissue tumors, while ganglion cyst (63.8%) is the most common tumor-like lesion. Benign bone tumors are larger in males than females (p:0.008). Lower extremity located of musculoskeletal tumors and tumor-like lesions is more common than upper extremity.Conclusions. In the Southeastern Anatolia region, benign bone and soft tissue tumors (osteochondroma and hemangioma) are more likely. The most common malignant tumors are chondrosarcoma and peripheral nerve sheath tumors. Additionally, it should not be forgotten that musculoskeletal system tumors are often located in the lower extremities.Keywords: Benign tumors, bone tumors, malign tumors, musculoskeletal tumors, soft tissue tumors, tumor-like lesions.Corresponding author: Özlem Orhan, Assistant professor of the Department of Orthopedics and Traumatology, Medical Faculty, Harran University, Sanlıurfa, Turkey. Postal code: 63300Address: Turkey, Sanlıurfa, Osmanbey campusPhone: +905057475401Email: droorhan@gmail.comJ Trauma Ortho Kaz 2023; 3 (69): 12-18Recieved: 28-07-2023Accepted: 11-09-2023 This work is licensed under a Creative Commons Attribution 4.0 International License
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.